510(k) Report

510(k) · Cleared

Cleared

Bongros HA

K090793510(k) TraditionalCleared May 19, 200956-day reviewClass II21 CFR 872.3930

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bioalpha, Inc. · LYC Bone Grafting Material, Synthetic

Cleared on May 19, 2009 as substantially equivalent to K981182 (Ceramed Dental, LLC, 1998) and 3 other predicates after a 56-day review. Its family tree reaches back 4 generations to 1987.

Decided
May 19, 2009
Review
56 days
Class
Class II
Product code
LYC
Recalls
None
Predicates
4

Its longest line of descent runs back 4 generations to K871773 (1987). 13 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 4 generations backK871773 Bio-Oss Pure Nat Hydroxyapatite Endoss ImplantGeistlich-Pharma · 1987
  2. 3 generations backK033815 Bio-Oss, Bio-Oss Blocks and Bio-Oss CollagenGeistlich-Pharma · 2004
  3. 2 generations backK043034 Osteoguide Anorganic Bone Mineral ProductsCollagen Matrix, Inc. · 2005 · Recalled
  4. 1 generation backK072397 Synoss Synthetic Bone Graft MaterialCollagen Matrix, Inc. · 2007
  5. This deviceK090793 Bongros HABioalpha, Inc. · 2009
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K871773Bio-Oss Pure Nat Hydroxyapatite Endoss ImplantGeistlich-Pharma1987—
−3K033815Bio-Oss, Bio-Oss Blocks and Bio-Oss CollagenGeistlich-Pharma2004—
−2K043034Osteoguide Anorganic Bone Mineral ProductsCollagen Matrix, Inc.20053
−1K072397Synoss Synthetic Bone Graft MaterialCollagen Matrix, Inc.2007—
0 (this device)K090793Bongros HABioalpha, Inc.2009—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199210
199530
199840
200010
FIG. 1 — Lineage of K090793, 1987–2009Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LYC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LYC device

  1. #1 K253317 Cytrans™ Elashieldscore 14.3 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (4)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K981182Osteograf/N-300
Summary page 1
…ctured and currently available in commercial distribution. Device Name Osteograf Endolion SynOss Bio-Oss 5 10(k) Number K981182 K980679 K072397 K952619 Decision SE SE SE SE…
Ceramed Dental, LLC1998—
*K980679Endobon
Summary page 1
…rrently available in commercial distribution. Device Name Osteograf Endolion SynOss Bio-Oss 5 10(k) Number K981182 K980679 K072397 K952619 Decision SE SE SE SE Product Cod…
Biomet, Inc.19981
*K072397Synoss Synthetic Bone Graft Material
Summary page 1
…ble in commercial distribution. Device Name Osteograf Endolion SynOss Bio-Oss 5 10(k) Number K981182 K980679 K072397 K952619 Decision SE SE SE SE Product Code LYC…
Collagen Matrix, Inc.2007—
*K952619Bio-Oss Ceramic
Summary page 1
…ial distribution. Device Name Osteograf Endolion SynOss Bio-Oss 5 10(k) Number K981182 K980679 K072397 K952619 Decision SE SE SE SE Product Code LYC LYC…
Geistlich-Pharma1995—

Also cleared against K981182: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 22 years and passes through 3 companies; a new generation was cleared every 2.2 years on median.
  • 2 of the 13 ancestors have a recall of any class.
  • 1 other device also cites its predicate K981182.

How does its category compare?

All LYC devices

LYC Bone Grafting Material, Synthetic: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.

FDA decisions per year · LYC

3in 2025

2007: 132008: 82009: 142010: 132011: 92012: 52013: 22014: 12016: 22020: 32022: 22025: 32026 (partial year): 3
2007high 14 (2009) · low 0 (2015)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LYC

267in 2025

2007: 80 days median2008: 73 days median2009: 100 days median2010: 164 days median2011: 224 days median2012: 120 days median2020: 156 days median2025: 267 days median2026 (partial year): 266 days median
2007high 267 (2025) · low 73 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LYC

1in 2018

2009: 12010: 22012: 22016: 22018: 1
2007high 2 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LYC

2in 2025

2007: 232008: 252009: 252010: 282011: 212012: 102013: 122014: 92015: 142016: 1402017: 192018: 142019: 152020: 52021: 122022: 62023: 92024: 62025: 2
2007high 140 (2016) · low 2 (2025)2025

MAUDE reports naming product code LYC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071380023
2008873025
200914100125
201013164228
20119224021
20125120210
20132—012
20141—09
20150—014
20162—2140
20170—019
20180—114
20190—015
2020315605
20210—012
20222—06
20230—09
20240—06
2025326702
202632660—

What is it indicated for?

Bongros®-HA (HAGS, HAGM, HAGL) is intended for use in dental surgery.

The products may be used in surgical procedures such as:

Augmentation or reconstructive treatment of the alveolar ridge

Filling of extraction sockets to enhance preservation of the alveolar ridge

Elevation of the maxillary sinus floor

Filling of peri-implant defects in conjunction with products intended for guided bone regeneration.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K090793: Bongros HA.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K090793

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026